CTRI/2024/06/068490
Not yet recruiting
Phase 4
Evaluation of efficacy of nitrous oxide inhalation sedation on childs anxiety and parental perception during dental procedures :A Randomised clinical trial - Nil
ANIL NEERUKONDA INSTITUTE OF DENTAL SCIENCES0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ANIL NEERUKONDA INSTITUTE OF DENTAL SCIENCES
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children under ASA I criteria
- •Anxious /phobic patients
- •Children with high fear susceptibility
- •Children with high gag reflex
- •Children with medical conditions aggravated by stress
Exclusion Criteria
- •Children below 4 years of age .
- •Children with ASA II and above.
- •Children with respiratory tract infections
- •Children with Chronic Obstructive Pulmonary Disease.
- •Children with bowel obstruction or abdominal pain
- •Children with middle ear infections/otitis media .
- •Children with vitamin B 12 deficiency
- •Children undergoing treatment with bleomycin sulphate.
- •Children with psychiatric disorders..
- •Children underwent surgery involving anterior part of maxilla.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Anxiolytic effect of N2OChildbirth Anxiety under spinal anesthesia.Mental and behavioural disorders associated with the puerperium, not elsewhere classifiedIRCT2012091510841N1Hamadan University Of Medical Science, Vice chancellor for research56
Recruiting
Not Applicable
sefulness of Pulsed Inhaled Nitric OXide (iNO) in adults with asymptomatic or mildly symptomatic COVID patients without pre-existing illness.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseasesCTRI/2021/05/033771Sir h n Reliance Foundation hospital and research centre
Completed
Not Applicable
Effects of nitric oxide inhalation therapy in the percutaneous ventricular assist device (Impella).JPRN-UMIN000050133Iwate Medical University50
Recruiting
Not Applicable
Clinical Application of exhaled Nitric Oxide measurements in PrimarY careAsthmaRespiratory - AsthmaACTRN12605000354684niversity of Otago200
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0 Level: LLT Classification code 10054933EUCTR2004-002312-29-GBINO Therapeutics800